Posts by Jay Goth
Redtail in Motion: September 2026
September’s Redtail in Motion celebrates a strong reception at the San Diego Small Business Expo and previews the official launch of Investment Lens and EVCR. Discover commercial milestones from Burble Neuro and Vessl Prosthetics, OK Stone’s latest funding update, and new founder conversations and upcoming investor events.
Read MoreRedtail in Motion: August 2026
August’s Redtail in Motion shares portfolio progress from Burble Neuro, OK Stone, and Vessl Prosthetics, alongside insights on scaling businesses and creating enterprise value. Explore new podcast episodes, our capital-raising conversation with Andy Murphy, and a preview of Redtail’s Small Business Expo workshop.
Read MoreRedtail in Motion: July 2026
July’s Redtail in Motion recaps a busy month of startup pitches, previews Investment Lens and EVCR, and explores fresh perspectives on enterprise value creation. Plus, catch four Innovation Insights conversations and a preview of our Meet the Founders webinar on preparing companies for capital raising.
Read MoreRedtail in Motion: June 2026
June’s Redtail in Motion highlights our investment in BMI OrganBank, Mammogen’s Series A financing of up to $30 million, and launch milestones from Burble Neuro and Vessl Prosthetics. Plus, explore new Innovation Insights podcasts, our first Meet the Founders webinar, and upcoming investor events.
Read MoreNew Research: In 9 of 10 Startup Pitch Decks, the Weakest Section Is the One Investors Decide On
Redtail Capital publishes findings from 205 analyses of 82 companies actively raising capital, and opens commercial access to Investment Lens™, the system used to produce an objective pitch deck analysis. Founders are being coached on the wrong half of the pitch deck. That is the central finding of research published today by Redtail Capital, drawn…
Read MorePrivate Equity’s Zombie Portfolio Companies Aren’t a Timing Problem
Zombie portfolio companies is the phrase private equity has settled on for its $860 billion problem. The roughly 4,500 U.S. businesses now classified as zombie portfolio companies are sitting in sponsor portfolios well past the exit dates their investment theses assumed. The industry is describing this as a liquidity problem, a timing problem, a market problem, essentially…
Read MoreThe Headline Price Isn’t the Deal: What Lower Middle-Market M&A Data Reveals About Value
Every business owner I meet has a value number in their head. Usually, it is a multiplier they heard at a conference that they applied to last year’s EBITDA and rounded up. It is the number they will expect when the letter of intent to purchase their business arrives. It is almost never the number…
Read MoreStrip the Veneer and Enterprise Value Creation Is a System
Why business needs fewer promises, fewer theories and a clearer path from diagnosis to measurable results. I was going through my Google Alerts for enterprise value creation when I came across an article with the rather ambitious title, “Galactic Alignment through Collective Evolution.” I clicked, not exactly sure what I expected. What I found was…
Read MoreWhat FreedomFest 2026 Revealed About America’s Innovation Conversion Rate
America’s innovation conversion rate, not its supply of ideas, is the number I could not stop thinking about on the drive home from Las Vegas. In early July I served as an investor judge at FreedomFest’s Principled Business Pitch Competition’s first round. Twenty-two founders with ninety seconds each to move from round one into the…
Read MoreThe $81 Billion Bet: Rethinking Merger Value Creation
The proposed $81 billion Paramount–Warner Bros. Discovery merger has been framed around one headline number: $6 billion in projected synergies. But does synergy alone create enterprise value? This article argues that financial models measure outcomes—not the structural alignment that determines long-term success. By examining the deal through the EVCR lens, it explores why durable merger…
Read More